Skip to content
Products
Resources
Company
Virtual lab
Keep in contact
Solid tumor
Blood cancer
Pharmacogenetics
Knowledge hub
Pubblications
About us
Virtual lab
Careers
Press hub
Contacts
Products
+
Solid tumor
Blood cancer
Pharmacogenetics
Resources
+
Knowledge hub
Pubblications
Company
+
About us
Virtual lab
Careers
Press hub
Contacts
Virtual lab
Keep in contact
Reserved Area
Publications
Publications
Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.
Filter
Year
All years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2008
Product line
All product lines
Easy
Easy PGX
Helix
Microsatelliti
Myriapod
Myriapod NGS
Realquant
Response
×
Remove filters
08.12.2016
Response
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications
27.11.2016
Response
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs
25.11.2016
Response
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Scientific Reports
08.11.2016
Response
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. Journal of Neuro-Oncology
11.10.2016
Myriapod
,
Response
The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients. Annals of Oncology
01.10.2016
Response
P06.13?A low baseline blood neutrophil count and a high percentage of Treg among leucocytes are associated with an increased overall survival of recurrent high-grade glioma patients treated with Bevacizumab. Neuro Oncology
01.10.2016
Response
P06.11 Classification of high-grade glioma using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry imaging (MALDI MSI): interim results of the GLIOMIC study. Neuro Oncology
22.09.2016
Response
Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker? PLOS One
31.08.2016
Myriapod
,
Response
Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology
21.08.2016
Myriapod
,
Response
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. The Oncologist
Previous
Page
1
Page
2
Page
3
Next